ATRA vs EXPD · rev $128.9M vs P/E 26, rev $10.60B
Atara Biotherapeutics Inc (ATRA) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
ATRA currently screens at market cap $87.1M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the ATRA and EXPD stock pages for the full models.
Not investment advice.